AzTrials
AzTrials

Physician RoundsNCT07215507

Timing of Physician Rounds for Antepartum Patients

A study testing Discovery Rounding and Standard Rounding in people with Physician Rounds and Communication, run by Duke University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will include patients admitted to the Antepartum service at Duke University Hospital, many of whom are managing high-risk pregnancies that require extended hospital stays and frequent physician interactions. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Physician Rounds, Communication
What is being tested?
Discovery Rounding and Standard Rounding
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
2 sitesUnited States
Study dates
4 Nov 2025to 20 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Pregnant women greater than 20 weeks gestation admitted to the antepartum list at Duke University Hospital

Who cannot join

  • Stillbirth
  • ICU admission
  • Admission to off-service unit
  • Active magnesium sulfate administration
  • Active severe hypertension or initiation of anti-hypertensive pathway within past 8 hours
  • Category II fetal heart rate tracing
Show all 11Show fewer
  • Other pregnancy/delivery complication precluding delayed rounding
  • Unstable/unsuitable condition per overnight team or attending physician
  • Previously enrolled/on active board >1 day at morning rounds
  • Postpartum readmission
  • Antepartum admission within the last 4 weeks

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Hannah Kelly, MD contact

832-967-7998

hannah.kelly@duke.edu

Rachel Wood, MD contact

rachel.wood@duke.edu

United States2 sites, 2 recruiting
  • Duke University Hospital

    Durham, North Carolina, 27710

    Caroline Oviedo, 786-301-2944‬, caroline.oviedo@duke.edu

    Rachel Wood, MD

    Not yet recruiting
  • Duke University Hospital

    Durham, North Carolina, 27710

    Caroline Oviedo, 786-301-2944‬, caroline.oviedo@duke.edu

    Hannah Kelly, MD, 832-967-7998, hannah.kelly@duke.edu

    Recruiting

Other trials in United States

About this study

Official title: Effect of Timing of Physician Rounds on Hospital Experience for High-Risk Antepartum Patients: A Randomized Controlled TrialTiming of Physician Rounds for Antepartum Patients

This study will include patients admitted to the Antepartum service at Duke University Hospital, many of whom are managing high-risk pregnancies that require extended hospital stays and frequent physician interactions. Currently, two rounding methods are used interchangeably for patients who do not have pregnancy or delivery complications that would preclude participation in delayed daytime rounding. This randomized controlled trial will compare two rounding models: the standard model, in which patients receive two rounds (an early morning bedside encounter and a later team discussion), and the intervention model, which consolidates both rounds into a single, later-morning bedside encounter following the team's review of clinical data. The primary objective is to assess whether consolidating physician rounds into a single, later-morning encounter-referred to as discovery rounding-improves patient satisfaction with communication.

Being tested
Discovery Rounding, Standard Rounding
Medical subject headings
Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Discovery RoundingBehavioural

    For certain patients with appropriate clinical risk factors, our service has adopted a policy of "discovery rounding". This method involves solely electronic health record chart review prior to the 8am attending-led Antepartum team discussion where the patient's overnight events are "discovered", clinical courses discussed, and daytime plans proposed. "Discovery rounding" consolidates bedside physician-patient encounters to one mid-morning interaction, forgoing early morning disturbances.

  • Standard RoundingBehavioural

    The current standard of rounding on the Antepartum service involves a preliminarily bedside encounter with patients between 5-7am by a resident +/- medical student before an attending physician-led Antepartum team discussion from 8-9am. The patient is then rounded on for a second time in the late morning by the entire Antepartum team where patient concerns are heard and care plans for the day are relayed/reiterated/cemented.

Study groups in NCT07215507
Study groupRoleWhat they receive
Standard RoundingActive comparatorThe current standard of rounding on the Antepartum service involves a preliminarily bedside encounter with patients between 5-7am by a resident +/- medical student before an attending physician-led Antepartum team discussion from 8-9am. The patient is then rounded on for a second time in the late morning by the entire Antepartum team where patient concerns are heard and care plans for the day are relayed/reiterated/cemented.
Receives: Behavioral: Standard Rounding
Discovery RoundingExperimentalFor certain patients with appropriate clinical risk factors, our service has adopted a policy of "discovery rounding". This method involves solely electronic health record chart review prior to the 8am attending-led Antepartum team discussion where the patient's overnight events are "discovered", clinical courses discussed, and daytime plans proposed. "Discovery rounding" consolidates bedside physician-patient encounters to one mid-morning interaction, forgoing early morning disturbances.
Receives: Behavioral: Discovery Rounding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of items rated as "Excellent" on the Communication Assessment Tool (CAT)

    The CAT measures patients' perceptions of physician communication across 15 specific behaviors, such as listening carefully, showing respect, explaining information clearly, and spending sufficient time with the patient. Each item is rated on a 5-point Likert scale ranging from "Poor" to "Excellent." By focusing on the frequency of "Excellent" ratings, the CAT provides a robust, patient-centered measure of the effectiveness and impact of physician communication during hospitalization.

    Measured: One of the following timepoints (whichever comes first for that patient); Hospital day 6 or the immediate postpartum period: postpartum day 0 or 1, depending on the time of delivery

Secondary outcomes (1)
  1. Edinburgh Postnatal Depression Scale (EPDS)

    A 10-item self-report questionnaire, validated for both postpartum and antepartum use, in which each item is scored 0-3 (total 0-30), with higher scores indicating greater depressive symptoms and a common cut-off of ≥13 suggesting possible clinical depression.

    Measured: At the 6 week postpartum visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2025
  2. Study start4 Nov 2025
  3. Primary completion30 Jan 2027 (estimated)
  4. Study completion20 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07215507
Sponsor's protocol ID
Pro00118226
Status last verified
Nov 2025
First submitted
8 Oct 2025
Last updated
29 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Discovery Rounding and Standard Rounding in people with Physician Rounds and Communication, run by Duke University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hannah Kelly, MD (832-967-7998, hannah.kelly@duke.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of items rated as "Excellent" on the Communication Assessment Tool (CAT) (time frame: One of the following timepoints (whichever comes first for that patient); Hospital day 6 or the immediate postpartum period: postpartum day 0 or 1, depending on the time of delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in